2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
US-12486248-B2 · Dec 2, 2025 · US
This page is not indexed by search engines while we improve data quality.
Eis Knut patents
Eis Knut is listed as an inventor on 70 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Eis Knut |
| Total patents | 70 |
| First publication | Feb 5, 2015 |
| Latest publication | Dec 2, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Compounds, compositions and methods for cancer patient stratification and cancer treatment
US-2024366620-A1 · Nov 7, 2024 · US
Compounds, compositions and methods for cancer patient stratification and cancer treatment
US-12053476-B2 · Aug 6, 2024 · US
2-Methyl-Quinazolines
US-2024083857-A1 · Mar 14, 2024 · US
2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh
US-2023365524-A1 · Nov 16, 2023 · US
4,5-annulated 1,2,4-triazolones
US-11787797-B2 · Oct 17, 2023 · US
2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
US-11713304-B2 · Aug 1, 2023 · US
2-(morpholin-4-yl)-1,7-naphthyridines
US-11529356-B2 · Dec 20, 2022 · US
Macrocyclic indole derivatives
US-11492358-B1 · Nov 8, 2022 · US
2-methyl-quinazolines
US-2022235013-A1 · Jul 28, 2022 · US
Recent patents
Latest publications not already listed above.
4H-pyrrolo[3,2-c]pyridin-4-one derivatives
US-11339157-B1 · May 24, 2022 · US
2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh
US-2022135536-A1 · May 5, 2022 · US
Compounds, compositions and methods for cancer treatment
US-11142522-B2 · Oct 12, 2021 · US
2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
US-11130745-B2 · Sep 28, 2021 · US
Compounds, compositions and methods for cancer patient stratification and cancer treatment
US-2021236504-A1 · Aug 5, 2021 · US
4,5-annulated 1,2,4-triazolones
US-2021188846-A1 · Jun 24, 2021 · US
2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh
US-2021188805-A9 · Jun 24, 2021 · US
Macrocyclic indole derivatives
US-10981932-B2 · Apr 20, 2021 · US
Compounds, compositions and methods for cancer patient stratification and cancer treatment
US-10966986-B2 · Apr 6, 2021 · US
4,5-annulated 1,2,4-triazolones
US-10968216-B2 · Apr 6, 2021 · US
Heteroarylbenzimidazole compounds
US-10894784-B2 · Jan 19, 2021 · US
2-(morpholin-4-yl)-1,7-naphthyridines
US-2020383991-A1 · Dec 10, 2020 · US
2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh
US-2020377472-A1 · Dec 3, 2020 · US
2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
US-10815215-B2 · Oct 27, 2020 · US
2-(morpholin-4-yl)-1,7-naphthyridines
US-10772893-B2 · Sep 15, 2020 · US
2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh
US-2020123129-A1 · Apr 23, 2020 · US
Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases
US-10604532-B2 · Mar 31, 2020 · US
Macrocyclic indole derivatives
US-2020087322-A1 · Mar 19, 2020 · US
Compounds, compositions and methods for cancer treatment
US-2020062741-A1 · Feb 27, 2020 · US
4,5-annulated 1,2,4-triazolones
US-2019375747-A1 · Dec 12, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Bayer Pharma AG | 52 |
| Broad Inst Inc | 24 |
| Bayer Ag | 19 |
| Bayer Ip Gmbh | 14 |
| Harvard College | 13 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 70 |
| A61P35/02 | 49 |
| A61K45/06 | 47 |
| A61P43/00 | 42 |
| A61K31/5377 | 31 |